1. Home
  2. KWR vs AVDL Comparison

KWR vs AVDL Comparison

Compare KWR & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quaker Houghton

KWR

Quaker Houghton

HOLD

Current Price

$155.39

Market Cap

2.5B

Sector

Industrials

ML Signal

HOLD

Logo Avadel Pharmaceuticals plc

AVDL

Avadel Pharmaceuticals plc

HOLD

Current Price

$21.55

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KWR
AVDL
Founded
1918
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
1985
1996

Fundamental Metrics

Financial Performance
Metric
KWR
AVDL
Price
$155.39
$21.55
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$149.25
$18.38
AVG Volume (30 Days)
135.5K
1.5M
Earning Date
02-23-2026
03-02-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,864,242,000.00
$248,517,000.00
Revenue This Year
$3.44
$65.47
Revenue Next Year
$4.15
$30.88
P/E Ratio
N/A
N/A
Revenue Growth
0.08
79.88
52 Week Low
$95.91
$6.38
52 Week High
$154.08
$23.57

Technical Indicators

Market Signals
Indicator
KWR
AVDL
Relative Strength Index (RSI) 72.02 58.63
Support Level $136.34 $21.45
Resistance Level $145.30 $21.56
Average True Range (ATR) 4.27 0.09
MACD 1.26 -0.05
Stochastic Oscillator 99.76 49.09

Price Performance

Historical Comparison
KWR
AVDL

About KWR Quaker Houghton

Quaker Houghton manufactures and sells a variety of industrial process fluids. The product portfolio of the company includes metal removal fluids, cleaning fluids, corrosion inhibitors, metal drawing and forming fluids, die-cast mold releases, heat treatment and quenchants, metal forging fluids, hydraulic fluids, specialty greases, offshore sub-sea energy control fluids, rolling lubricants, rod and wire drawing fluids and surface treatment chemicals. The geographic segments of the company include America, EMEA, Asia/Pacific, and Global Specialty Businesses. The majority of the revenue is earned from America.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: